Kurek, Kyle C <br/><br/>
Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression.  [electronic resource] 

 -  Cancer research  Jul 2010 
 - 5577-86 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1538-7445 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-09-4602  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--physiology<br/>Bone Neoplasms--drug therapy<br/>Cell Growth Processes--physiology<br/>Cell Line, Tumor<br/>Cell Movement--physiology<br/>Core Binding Factor Alpha 1 Subunit--biosynthesis<br/>Disease Progression<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Mice<br/>Mice, Nude<br/>Osteosarcoma--drug therapy<br/>Oxidoreductases--biosynthesis<br/>Transcriptional Activation<br/>Tumor Suppressor Proteins--biosynthesis<br/>WW Domain-Containing Oxidoreductase